ARCHIVES

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004